ArticleBone marrow transplantation2022

Impact of donor-derived CD34 + infused cell dose on outcomes of patients undergoing allo-HCT following reduced intensity regimen for myelofibrosis: a study from the Chronic Malignancies Working Party of the EBMT.

Tomasz Czerw et al.PubMed ↗Publisher ↗

No numbers read from the abstract.